Biotech

All Articles

Biogen containers SAGE-324 partnership after crucial tremor stop working

.Biogen has actually carried out the last ceremonies to its own partnership with Sage Therapeutics o...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel purchase ratings

.On the same day that some Parkinson's ailment medicines are actually being disputed, AbbVie has act...

Arch shuts $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arc Project Partners is a...

Orion to utilize Aitia's 'digital twins' to find new cancer cells medications

.Finnish biotech Orion has spied prospective in Aitia's "digital identical twin" technology to creat...

Windtree's surprise med brings up high blood pressure in newest phase 2 gain

.While Windtree Therapies has had a hard time to expand the economic roots required to endure, a per...

2 cancer cells biotechs combine, producing worldwide footprint

.OncoC4 is actually taking AcroImmune-- and its own internal professional production capabilities-- ...

Amgen files first period 3 gain for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the very first period 3 data on its $400 million dermatitis medicin...

Biogen, UCB file phase 3 lupus win after stopping working earlier test

.Biogen and UCB's gamble on improving in to phase 3 on the back of an unsuccessful research study lo...

Aptadir hopes new RNA inhibitors can easily turn around difficult cancers

.Italian biotech Aptadir Therapies has actually launched with the guarantee that its own pipe of pre...

Wave surfs DMD effectiveness to regulators' doors, sending out stockpile

.Wave Lifestyle Sciences has satisfied its objective in a Duchenne muscular dystrophy (DMD) study, i...